FAST's New Investigator Award funds early-career researchers launching translational science projects focused on Angelman syndrome.
Funder: Foundation for Angelman Syndrome Therapeutics (FAST)
Due Dates: Rolling (no fixed deadline)
Funding Amounts: Up to $150,000 per year for 1–2 years; larger budgets possible with justification.
Summary: Supports early-career researchers launching translational research programs focused on Angelman syndrome.
Key Information: Applicants must be within first five years of an academic appointment; nonprofit institutions only.
The New Investigator Award from the Foundation for Angelman Syndrome Therapeutics (FAST) is designed to attract and support outstanding early-career scientists as they establish translational research programs focused on Angelman syndrome (AS). The program aims to foster innovative ideas and help develop the next generation of leaders in AS research, with an emphasis on projects that have the potential to advance understanding and treatment of Angelman syndrome.